Analysis of the availability of bronchodilators and anti-inflammatory drugs for patients with chronic obstructive pulmonary disease

QR Code

Analysis of the availability of bronchodilators and anti-inflammatory drugs for patients with chronic obstructive pulmonary disease

Background. The study of drug availability for patients with chronic obstructive pulmonary disease (COPD) represents one of the priority tasks in the organization of effective counteraction to COPD in the Russian Federation.Objective: to assess drug prices, affordability, and availability for COPD p...

Full description

Saved in:

Bibliographic Details
Main Authors:	E. A. Orlova, V. I. Petrov, I. P. Dorfman, O. V. Shatalova, M. A. Orlov
Format:	Article
Language:	Russian
Published:	IRBIS LLC 2024-05-01
Series:	Фармакоэкономика
Subjects:	chronic obstructive pulmonary disease copd drug prices drug affordability drug availability atc/ddd analysis
Online Access:	https://www.pharmacoeconomics.ru/jour/article/view/964
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Clinical and economic analysis of drug costs in a general hospital in 2014-2018
by: A. T. Burbello, et al.
Published: (2020-02-01)

Analysis of methotrexate use practice in patients with rheumatoid and psoriatic arthritis
by: S. A. Doktorova, et al.
Published: (2025-05-01)

Analysis of the availability and affordability of pharmaceuticals for children in need of palliative care
by: D. M. Medvedeva, et al.
Published: (2021-07-01)

POLYPHARMACY IN MANAGMENT OF IN-PATIENTS WITH NOVEL CORONAVIRUS DISEASE (COVID-19)
by: V. I. Petrov, et al.
Published: (2022-07-01)

Appointment of Antimicrobial Medications in a Hospital Depending on the Results of Microbiological Monitoring of HAI
by: S. D. Mitrokhin, et al.
Published: (2020-12-01)

Analysis of the Consumption of Medicinal Products Associated with a High Risk of Drug-Induced Liver Injury in Patients with COVID-19
by: V. I. Petrov, et al.
Published: (2024-10-01)

РОЛЬ АТС/DDD-МЕТОДОЛОГИИ В ОПТИМИЗАЦИИ ЛЕЧЕНИЯ БОЛЬНЫХ С ОСТРЫМ КОРОНАРНЫМ СИНДРОМОМ
by: А. Л. Хохлов, et al.
Published: (2013-02-01)

Contemporary State of Antibiotic Resistance in Opportunistic Pathogens and the Extent of Antibiotic Use in the Third-Level Federal Obstetric Hospital
by: D. M. Serdyukova, et al.
Published: (2020-05-01)

Analysis of the availability of bronchodilators listed in the medical insurance catalog for treatment of chronic obstructive pulmonary disease in community health service centers in Shanghai
by: DENG Hui, et al.
Published: (2025-05-01)

Improving the Inhalation Technique in Patients with Obstructive Pulmonary Diseases
by: Zlatina Ivanova, et al.
Published: (2016-12-01)

Implications and size of trade in anti-infective drugs a.u.v. and About the drafting of medical and veterinary ordinances in Romania
by: Romeo T. Cristina
Published: (2023-06-01)

ADMINISTRATIVE AND ORGANIZATIONAL ASPECTS OF FUNCTIONING OF THE SYSTEM OF AVAILABILITY NARCOTIC AND PSYCHOTROPIC MEDICINAL PREPARATIONS FOR PATIENTS WHO NEED THEM
by: I. A. Kaminskaya, et al.
Published: (2017-03-01)

Dynamics of prices and consumption of anticancer drugs in Russia after their generics and biosimilars became available
by: F. V. Gorkavenko, et al.
Published: (2019-07-01)

Improving Pulmonary Delivery of Budesonide Suspensions Nebulized with Constant-Output Vibrating Mesh Nebulizers by Using Valved Holding Chamber
by: Tomasz R. Sosnowski, et al.
Published: (2025-05-01)

Geographical and temporal variations in availability of national price negotiated novel anticancer drugs: a spatial statistical study based on two cross-sectional datasets in China
by: Ziqi Zhao, et al.
Published: (2025-07-01)

Levels of T-regulatory cells in patients with chronic obstructive pulmonary disease and basis therapy efficiency
by: N. A. Kirillova, et al.
Published: (2012-12-01)

Regional aspects of availability of expectorants and antitussive drugs
by: V. М. Timiryanova, et al.
Published: (2025-02-01)

Availability and Affordability of Medicines for the Treatment of Cardiovascular Diseases in Pharmacies in Six Regions of the Russian Federation
by: A. E. Imaeva, et al.
Published: (2019-01-01)

Sub-Optimal Chronic Obstructive Pulmonary Disease (COPD) Management in India: Findings from a Community-Based Study
by: Jarhyan P, et al.
Published: (2025-06-01)

Utilization and Determinants of Anticancer Drugs Under China&rsquo;s National Drug Price Negotiation Policy
by: Tuo B, et al.
Published: (2025-07-01)

ANALYSIS OF THE PRICING OF MEDICINAL DRUGS IN THE CURRENT ECONOMIC CLIMATE
by: N. M. Bat, et al.
Published: (2015-12-01)

EFFECT OF BRONCHODILATORS ON HEART RATE VARIABILITY IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
by: H. H. Shugushev, et al.
Published: (2015-12-01)

MANAGEMENT ASPECT OF THE PROBLEM OF NARCOTIC DRUGS USE
by: S. Yu. Soboleva, et al.
Published: (2016-09-01)

The study of price situation on the domestic antiplatelet market
by: Ye. А. Redkina, et al.
Published: (2017-08-01)

Comparative analysis of antipsychotic drug consumption for inpatient schizophrenia treatment: a retrospective study with 5-year follow-up
by: L. B. Vaskova, et al.
Published: (2020-11-01)

DDD and DU90% Analysis of Antimicrobial Therapy of Community-Acquired Pneumonia in the In-Patient Department of the Federal Center
by: O. V. Zhukova, et al.
Published: (2020-05-01)

The role of the microbiota components in modification of the immune response in some cases of chronic obstructive pulmonary disease
by: Natalia A. Kirillova, et al.
Published: (2017-07-01)

ROAD MAP FOR DEVELOPMENT OF PRICE REGULATION SYSTEM AND SYSTEM OF DRUG SUPPLY AT THE EXPENSE OF RUSSIAN FEDERATION HEALTHCARE SYSTEM FUNDS
by: M. V. Sura, et al.
Published: (2015-05-01)

T-regulatory cells subpopulation in bronchial asthma and heterogeneous phenotypes of chronic obstructive pulmonary disease
by: N. A. Kirillova, et al.
Published: (2011-02-01)

Efficiency of various methods of injection of antituberculosis agents in young patients with destructive pulmonary tuberculosis
by: I. A. Morozov, et al.
Published: (2016-09-01)

Review of the monograph by Kolbin A. S., Zyryanov S. K., Belousov D. Yu. "Pharmacovigilance" 2025
by: V. I. Petrov
Published: (2025-01-01)

Support Needs of Patients with Chronic Obstructive Pulmonary Disease (COPD) and Asthma Throughout Their Patient Journey: A Qualitative Study
by: Almonacid C, et al.
Published: (2025-07-01)

IS RUSSIA READY FOR THE INTRODUCTION OF THE NATIONAL REFERENCE PRICING SYSTEM?
by: V. V. Omelyanovskiy
Published: (2015-05-01)

Risk of Severe Exacerbation Associated with Gabapentinoid Use in Patients with Chronic Obstructive Pulmonary Disease: A Population-Based Cohort Study
by: Omotayo Olaoye, et al.
Published: (2025-12-01)

Study of affordability of pharmaceutical provision for type 2 diabetes therapy in Ukraine
by: I.O. Vlasenko, et al.
Published: (2025-06-01)

PHARMACO-ECONOMIC ANALYSIS OF COST IN TERMS OF MAINTENANCE OF PREFERENTIAL MEDICINES PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE ON THE TERRITORY OF KRASNOYARSK REGION
by: T. V. Gaygolnik, et al.
Published: (2016-09-01)

ASSESSMENT OF AIR TRAFFIC CONTROL UNIT LOAD INFLUENCE ON ECONOMIC EFFICIENCY OF FLIGHTS
by: V. K. Pechenezhskiy, et al.
Published: (2016-11-01)

An overview of the therapeutic applications of cinnamon-loaded in nanosystems
by: Ali Asadi, et al.
Published: (2025-07-01)

Chronic obstructive pulmonary disease and chronic heart failure in elderly people: literature review
by: V. A. Gubkina, et al.
Published: (2016-06-01)

Loss of appetite in patients with chronic obstructive pulmonary disease - a mixed methods study
by: Marie Louise Bergmann, et al.
Published: (2025-12-01)